Prognostic significance of <scp>CKS2</scp> and <scp>CD47</scp> expression in patients with gastric cancer who underwent radical gastrectomy

医学 癌症 临床意义 胃肠病学 内科学 免疫组织化学 胃切除术 阶段(地层学) 存活率 病理 生物 古生物学
作者
Yang Zhou,Jing Zeng,Wei Zhou,Keyan Wu,Zhen Tian,Weigan Shen
出处
期刊:Scandinavian Journal of Immunology [Wiley]
卷期号:96 (4)
标识
DOI:10.1111/sji.13198
摘要

To investigate the protein expression levels of cyclin-dependent kinase subunit 2 (CKS2) and the cluster of differentiation (CD) 47 in gastric cancer (GC) and their clinical significance. A total of 126 GC patients who underwent radical resection were selected as study subjects. Additionally, 32 patients with benign gastric tumour, 42 patients with low-grade intraepithelial neoplasia (LGIEN), and 49 patients with high-grade intraepithelial neoplasia (HGIEN) who underwent surgery were selected as the control groups. Immunohistochemistry was used to detect the expression of CKS2 and CD47 in surgical specimens. We statistically analysed the clinical significance of the expression of the two factors. (1) The positivity rates for CKS2 in benign gastric tumour tissue, LGIEN tissue, HGIEN tissue, and GC tissue gradually increased, that is, 6.3% (2/32), 30.9% (13/42), 38.8% (19/49), and 60.3% (76/126), respectively, and the positivity rates for CD47 were 18.8% (6/32), 38.1% (16/42), 46.9% (23/49), and 65.9% (83/126), respectively. (2) High expression of CKS2 and CD47 were associated with tumour diameter, Lauren classification, number of lymph node metastases, and TNM stage. In addition, the immunohistochemical scores for CKS2 and CD47 were positively correlated (r = .625, P = .000). (3) The median follow-up time of 126 patients was 46.5 months, and the overall survival (OS) rate was 40.5% (51/126). Survival analysis showed that compared with that in the CKS2 (−) group, the OS rate for patients in the CKS2 (+) group was significantly worse and that compared with the CD47 (−) group, the CD47 (+) group had significantly worse OS (30.1% vs 60.5%, χ2 = 15.67, P = .000). (4) The OS rates of CKS2 (+) CD47 (+) group, CKS2 (+) CD47 (−) group, CKS2 (−) CD47 (+) group, and CKS2 (−) CD47 (−) group were 20.0% (13/65), 58.3% (7/12), 57.1% (8/14), 65.7% (23/35), respectively, the prognosis of patients in CKS2 (+) CD47 (+) group was significantly poor. High expression levels of CKS2 and CD47 were closely related to the occurrence of GC and can be used as independent risk factors to assess the prognosis of patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Hus11221完成签到,获得积分10
刚刚
tt大耳朵完成签到,获得积分10
刚刚
刚刚
qiao应助DYDSA采纳,获得25
2秒前
笨笨忘幽发布了新的文献求助10
3秒前
落寞凌柏完成签到,获得积分10
4秒前
辣辣完成签到,获得积分10
4秒前
wqmdd发布了新的文献求助10
5秒前
晴天完成签到,获得积分10
5秒前
丘比特应助风趣的梦露采纳,获得10
5秒前
Brady6完成签到,获得积分10
6秒前
苗广山完成签到,获得积分10
10秒前
悠悠完成签到 ,获得积分10
10秒前
HEAUBOOK应助wqmdd采纳,获得10
10秒前
彭于晏应助笨笨忘幽采纳,获得30
11秒前
cmy完成签到,获得积分10
13秒前
独自受罪完成签到 ,获得积分10
13秒前
16秒前
呵呵哒发布了新的文献求助30
18秒前
逃离地球完成签到 ,获得积分10
19秒前
23秒前
蒋时晏应助高大凌寒采纳,获得200
26秒前
小摩尔完成签到 ,获得积分10
30秒前
任风完成签到,获得积分10
32秒前
小乐儿~完成签到,获得积分10
33秒前
华仔应助斯文的傲珊采纳,获得10
34秒前
香冢弃了残红完成签到,获得积分10
34秒前
yao chen完成签到,获得积分10
34秒前
妙手回春板蓝根完成签到,获得积分10
36秒前
抹茶拿铁加奶砖完成签到 ,获得积分10
37秒前
不缺人YYDS完成签到,获得积分10
42秒前
223311完成签到,获得积分10
49秒前
传奇3应助mili采纳,获得10
50秒前
遗迹小白完成签到,获得积分10
52秒前
llllzzh完成签到 ,获得积分10
57秒前
清修完成签到,获得积分10
1分钟前
接accept完成签到 ,获得积分10
1分钟前
章铭-111完成签到 ,获得积分10
1分钟前
小宇哥LB完成签到 ,获得积分10
1分钟前
孤鸿影98完成签到 ,获得积分10
1分钟前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
Technologies supporting mass customization of apparel: A pilot project 450
Mixing the elements of mass customisation 360
Периодизация спортивной тренировки. Общая теория и её практическое применение 310
the MD Anderson Surgical Oncology Manual, Seventh Edition 300
Nucleophilic substitution in azasydnone-modified dinitroanisoles 300
Political Ideologies Their Origins and Impact 13th Edition 260
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3780920
求助须知:如何正确求助?哪些是违规求助? 3326387
关于积分的说明 10226987
捐赠科研通 3041612
什么是DOI,文献DOI怎么找? 1669520
邀请新用户注册赠送积分活动 799081
科研通“疑难数据库(出版商)”最低求助积分说明 758734